CN213759849U - Disposable three oxygen autoblood handles and uses pipeline - Google Patents
Disposable three oxygen autoblood handles and uses pipeline Download PDFInfo
- Publication number
- CN213759849U CN213759849U CN202022044147.4U CN202022044147U CN213759849U CN 213759849 U CN213759849 U CN 213759849U CN 202022044147 U CN202022044147 U CN 202022044147U CN 213759849 U CN213759849 U CN 213759849U
- Authority
- CN
- China
- Prior art keywords
- pipe
- bottle
- blood
- disposable
- pressure gas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000001301 oxygen Substances 0.000 title claims abstract description 30
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 30
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 239000007789 gas Substances 0.000 claims abstract description 51
- 230000004927 fusion Effects 0.000 claims abstract description 35
- 230000005540 biological transmission Effects 0.000 claims abstract description 28
- 239000003814 drug Substances 0.000 claims abstract description 17
- 230000001681 protective effect Effects 0.000 claims abstract description 13
- 238000011282 treatment Methods 0.000 claims description 62
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 6
- 229920001893 acrylonitrile styrene Polymers 0.000 claims description 3
- 238000001746 injection moulding Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 94
- 210000004369 blood Anatomy 0.000 abstract description 94
- 230000001225 therapeutic effect Effects 0.000 description 17
- 229920003023 plastic Polymers 0.000 description 13
- 239000004033 plastic Substances 0.000 description 13
- 210000004761 scalp Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000023555 blood coagulation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004880 explosion Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000010241 blood sampling Methods 0.000 description 2
- POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 241001411320 Eriogonum inflatum Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model discloses a disposable three oxygen autoblood handles and uses pipeline, including the integrated into one piece's fusion bottle, the fusion bottle includes body and three communicating pipes, communicating pipe intercommunication the inside of body, the first communicating pipe is linked as an organic whole with the dosing pipe, the second communicating pipe is linked as an organic whole with the gas-supply pipe, the third communicating pipe is linked as an organic whole with the gas-supply pipe; the gas transmission pipe is provided with a gas transmission tee joint, and the gas transmission tee joint is respectively connected with a positive pressure gas transmission pipe and a negative pressure gas transmission pipe; the tail ends of the positive pressure gas pipe and the negative pressure gas pipe are provided with interfaces; the blood conveying pipe is fixedly connected with the lower part of the bottle body, the blood conveying pipe is respectively provided with a detachable female connector, a detachable male connector, a drip cup, a flow regulator and a needle head connector, the positive pressure gas conveying pipe, the negative pressure gas conveying pipe and the blood conveying pipe are respectively provided with a flow stopping clamp, and the medicine feeding pipe, the connector and the needle head connector are respectively detachably connected with a protective cap.
Description
Technical Field
The utility model relates to a medical equipment's technical field particularly, relates to a disposable three oxygen autologous blood deals with and uses pipeline.
Background
The trioxane autoblood therapy is a non-drug treatment technology, which is equivalent to establishing a temporary collateral circulation passage outside a patient, sucking 200ml of venous blood of the patient into a fusion bottle, adding a certain concentration of isochoric trioxane for fusion treatment with the venous blood, and then rapidly returning the venous blood to the patient, thus finishing the treatment of the trioxane autoblood with a small dose; if the patient needs the disease, the blood can be repeatedly collected and then returned for transfusion, which is called high-dose trioxane autoblood treatment. In recent years, trioxane autoblood therapy is actively being developed in China.
At present, the instruments for three oxygen and blood fusion only have two kinds of vacuum flask and plastics blood bag, and all have a great deal of problems:
first, the problems of the vacuum bottle:
1.1 explosion bottle, wherein the vacuum bottle suddenly bursts during treatment, so that the blood of a patient splashes, the treatment is stopped, and the patient is frightened to cause medical dispute; the method is found out that some empty bottles have cracks when leaving the factory and are purely quality problems except for part of transportation reasons;
1.2 foreign matters such as hair, spots, tiny impurities and the like are occasionally seen in the vacuum bottle;
1.3 the bottle stopper is loosened to cause vacuum leakage and the bottle is scrapped;
1.4 the vacuum bottle has no medicine adding function and is inconvenient to use;
1.5 vacuum bottles are imported from remote Germany, have many uncertainties and are in urgent need for localization.
Secondly, the plastic blood bag has the following problems:
2.1 there are four open processes of contaminating the treated blood in the treatment;
2.2 the contact between the plastic blood bag and the trioxane can release two chemical substances of polyvinyl chloride and phthalate, and the chemical substances can induce the gene mutation and the toxicity activation of the organism after polluting the treated blood;
2.3 the technology is laggard, the thick and long needle is used for venipuncture once, and only 100ml of blood can be treated by using one set of consumables;
2.4 Plastic blood bags were approved only for storing blood and never for use in trioxane and blood fusion treatments.
To the problem at present effectual solution not yet, the utility model provides a solution.
SUMMERY OF THE UTILITY MODEL
To solve the above technical problems in the related art, the present invention provides a disposable trioxane autoblood treatment pipeline, which has functions of blood collection, treatment of treated blood with trioxane, and reinfusion of treated blood, and is performed in a fully-enclosed treatment system; this three oxygen of disposable autoblood handles with pipeline capacity is big, durable, not fragile, fuses bottle and adds medicine pipeline, gas transmission pipeline, blood transfusion pipeline integrated into one piece, neither has the hidden danger of exploding the bottle, also does not have the trouble of connecting before the treatment, also does not have the not hard up risk of droing of bottle plug, more does not have the possibility of open pollution.
In order to achieve the technical purpose, the technical scheme of the utility model is realized as follows:
a disposable three oxygen autoblood disposes and uses the pipeline, including the integrally formed fusion bottle, said fusion bottle includes body and three communicating pipes, the said communicating pipe connects the inside of the said body, the first said communicating pipe links with the medicine-adding pipe as an organic whole, the second said communicating pipe links with the gas-supply pipe as an organic whole, the third said communicating pipe links with the blood-supply pipe as an organic whole; the gas transmission pipe is provided with a gas transmission tee joint, and the gas transmission tee joint is respectively connected with a positive pressure gas transmission pipe and a negative pressure gas transmission pipe; the tail ends of the positive pressure gas pipe and the negative pressure gas pipe are provided with interfaces; the blood transfusion tube is fixedly connected with the lower part of the bottle body, the blood transfusion tube is respectively provided with a detachable female connector, a detachable male connector, a drip cup, a flow regulator and a needle connector, the positive pressure gas pipe, the negative pressure gas pipe and the blood transfusion tube are respectively provided with a flow stopping clamp, and the connector and the needle connector are respectively detachably connected with a protective cap.
Further, the dosing tube is plugged through a rubber elastic piece.
Furthermore, the medicine feeding pipe and the communicating pipe are fixedly connected with the upper left part of the bottle body.
Further, the dosing tube is detachably connected with a dosing tube protective cap.
Furthermore, the fusion bottle is formed by one-time injection molding of an acrylonitrile-styrene copolymer material.
Further, the capacity of the fusion bottle was 300 ml.
Furthermore, the fusion bottle also comprises a hook which is fixedly connected with the upper part of the fusion bottle.
Furthermore, the fusion bottle can make light pass through, be provided with the scale mark on the fusion bottle.
The utility model has the advantages that:
1. when in use, the utility model can directly connect the equipment without connecting at present and can be unpacked for treatment;
2. the utility model avoids the potential safety hazards of loose bottle plug, falling off, bottle explosion, foreign matter and the like when the vacuum bottle is used;
3. the utility model avoids the four times of open pollution in the plastic blood bag treatment and the harm of two chemical substances to the blood of a patient (polyvinyl chloride and phthalate);
4. the utility model has the capacity of 300ml, small dose treatment, one reciprocating sampling and transfusion can carry out three oxidation treatment on 200ml of blood; high dose therapy, which can be repeated 10 times within 60 minutes, totaling 2000ml of blood treated with trioxides:
4.1 compared with the plastic blood bag, the utility model can only collect and transfuse 100ml of blood for one treatment, the collection and transfusion of 200ml of blood for one treatment of the utility model is 2 times of the treatment amount of the plastic blood bag for one treatment, and the treatment of large dose is 20 times of the treatment amount of the plastic blood bag for one treatment;
4.2 compared with the plastic blood bags for 20 times of treatment, the utility model can accumulate the blood volume of 2000ml for collection and transfusion, and can save at least 19 plastic blood bags for medical treatment units in one treatment, thus reducing the cost of clinical treatment by 1000-2000 yuan, but increasing the medical pure benefit by N times;
4.3 the treatment amount of the utility model is equal to the treatment amount of the plastic blood bag for 20 times, which can reduce the pain of the patient caused by the vein puncture with 19 needles and reduce the pain caused by the hospital to and fro 19 times; the workload of 19 treatments for medical staff is also reduced.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required to be used in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without creative efforts.
Fig. 1 is a schematic view of a disposable trioxane autoblood treatment line according to an embodiment of the present invention.
In the figure:
1. a bottle body; 2. a communicating pipe; 3. a medicine feeding pipe; 4. a dosing tube protective cap; 5. hooking; 6. a gas delivery pipe; 7. a gas transmission tee joint; 8. a positive pressure gas delivery pipe; 9. a negative pressure gas delivery pipe; 10. an interface; 11. a blood transfusion tube; 12. a detachable female joint; 13. a detachable male connector; 14. a drip cup; 15. a flow regulator; 16. a needle connector; 17. a flow stopping clip; 18. a protective cap.
Detailed Description
The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. It is to be understood that the embodiments described are only some embodiments of the invention, and not all embodiments. All other embodiments obtained by a person skilled in the art based on the embodiments of the present invention belong to the protection scope of the present invention.
As shown in fig. 1, according to the embodiment of the present invention, a disposable three oxygen autoblood disposal pipeline comprises an integrally formed fusion bottle, wherein the fusion bottle comprises a bottle body 1 and three communicating pipes 2, the communicating pipes 2 communicate with the inside of the bottle body 1, a first communicating pipe 2 is connected with a medicine feeding pipe 3, a second communicating pipe 2 is connected with a gas conveying pipe 6, and a third communicating pipe 2 is connected with a blood conveying pipe 11; the gas transmission pipe 6 is provided with a gas transmission tee 7, and the gas transmission tee 7 is respectively connected with a positive pressure gas transmission pipe 8 and a negative pressure gas transmission pipe 9; the tail ends of the positive pressure air conveying pipe 8 and the negative pressure air conveying pipe 9 are respectively provided with a connector 10; the blood conveying pipe 11 is fixedly connected with the lower part of the bottle body 1, the blood conveying pipe is respectively provided with a detachable female connector 12, a detachable male connector 13, a drip cup 14, a flow regulator 15 and a needle connector 16, the positive pressure air conveying pipe 8, the negative pressure air conveying pipe 9 and the blood conveying pipe 11 are respectively provided with a flow stopping clamp 17, and the connector 10 and the needle connector 16 are respectively detachably connected with a protective cap 18.
In a specific embodiment of the present invention, the dosing tube 3 is sealed by a rubber elastic member.
In an embodiment of the present invention, the medicine feeding tube 3 and the communicating tube 2 are fixedly connected to the upper left portion of the bottle body 1.
In a specific embodiment of the present invention, the medicine feeding tube 3 is detachably connected to a medicine feeding tube protecting cap 4.
In one embodiment of the present invention, the fusion bottle is made of acrylonitrile-styrene copolymer by one-step injection molding.
In one embodiment of the present invention, the fusion bottle has a capacity of 300 ml.
In a specific embodiment of the present invention, the fusion bottle further comprises a hook 5, and the hook 5 is fixedly connected to the upper portion of the fusion bottle.
In a specific embodiment of the present invention, the fusion bottle is transparent to light, and the fusion bottle is provided with scale marks.
For the convenience of understanding the above technical solutions of the present invention, the above technical solutions of the present invention are explained in detail through specific use modes below.
Firstly, preparation work before clinical treatment:
1.1, taking 2 disposable hydrophobic filters (accessories), aligning the disposable hydrophobic filters (accessories) to a positive pressure air outlet and a negative pressure air outlet on a trioxane therapeutic apparatus, and connecting and screwing;
1.2, taking a disposable trioxane autoblood treatment pipeline, and closing flow stopping clamps 17 on a positive pressure gas conveying pipe 8 and a negative pressure gas conveying pipe 9 in sequence;
1.3 respectively taking down the protective caps 18 on the interfaces 10 of the positive pressure gas pipe 8 and the negative pressure gas pipe 9, and respectively aligning the protective caps to the installed hydrophobic filters on the positive pressure gas outlet and the negative pressure gas outlet of the trioxane therapeutic apparatus to be connected and screwed;
1.4 closing the flow stopping clamp 17 and the flow regulator 15 on the blood conveying pipe 11;
1.5 removing the protective cap 18 on the needle connector 16 of the blood transfusion tube 11, and tightly connecting the needle connector 16 with a scalp needle (accessory) for standby;
1.6 so far, the disposable three oxygen autoblood treatment pipeline and the three oxygen therapeutic apparatus form a totally-enclosed therapeutic system, and the preparation work before clinical treatment is finished.
Secondly, application in clinical treatment:
2.1 blood collection:
2.1.1 starting the three-oxygen therapeutic apparatus, and starting to vacuumize;
2.1.2 opening the negative pressure air delivery pipe 9 and the flow stopping clamp 17 on the blood delivery pipe 11 in sequence;
2.1.3 selecting a puncture part for routine disinfection, taking down a scalp needle protective cap, puncturing a scalp needle into a vein to see blood return, opening a flow regulator 15 on a blood transfusion tube 11, and quickly pumping the blood into the fusion bottle body 1;
2.1.4 taking down the protective cap 4 of the drug adding tube 3, puncturing the syringe needle filled with the anticoagulant into the bottle body 1 from the sterilized drug adding tube 3, sucking the anticoagulant, and slightly shaking the bottle body 1 to fully mix the anticoagulant with blood for anticoagulation;
2.1.5 setting the concentration of the treated ozone on the ozone therapeutic apparatus;
2.1.6 when the blood is collected to the 200ml scale, closing the flow regulator 15 of the blood conveying pipe 11, closing the flow stopping clamp 17 on the negative pressure gas conveying pipe 9 and closing the negative pressure key of the three-oxygen therapeutic apparatus in sequence;
2.2 adding ozone for reinfusion:
2.2.1 starting a positive pressure key of the three-oxygen therapeutic apparatus, manually instructing to pressurize to 0.9bar, starting a flow stopping clamp 17 on a positive pressure gas transmission pipe 8, starting a flow regulator 15 on a blood transmission pipe 11, and returning blood fused with the three oxygen;
2.2.2 returning the concentration of the ozone to zero, manually instructing the ozone therapeutic apparatus to continue to increase the positive pressure, and quickly returning the ozone-treated blood to the body of the patient;
2.2.3 when the blood is returned to the position of 1-2 cm above the drip cup 14 on the blood transfusion tube 11, closing the flow regulator 15, closing the positive pressure key of the three-oxygen therapeutic apparatus, and stopping the return transfusion;
2.2.4 further closing the flow stopping clamp 17 on the positive pressure gas transmission pipe 8, opening the negative pressure key on the three-oxygen therapeutic apparatus, opening the flow stopping clamp 17 on the negative pressure gas transmission pipe 9, opening the flow regulator 15 on the blood transmission pipe 11, again extracting the blood of the patient, repeating the above steps for N times according to the disease condition of the patient, and using a set of consumable materials to totally collect and carry out three-oxidation treatment on N200 ml blood by one needle;
2.3 jam or blood coagulation's processing three oxygen autoblood treatment in-process often can take place to block up or blood coagulation, for solving and meet this condition and neither waste the person's blood of treating, again uninterrupted therapy, the utility model discloses will get rid of according to following procedure and block up or blood coagulation:
2.3.1 if blood is collected, immediately closing the flow regulator 15 on the blood conveying pipe 11, then closing the flow stopping clamp 17 on the blood conveying pipe 11, and then closing the negative pressure key of the three-oxygen therapeutic apparatus;
2.3.2 if the blood is being returned, immediately closing the positive pressure key of the three-oxygen therapeutic apparatus, starting to vacuumize, and then sequentially closing the flow regulator 15 and the flow stopping clip 17 on the blood conveying pipe 11;
2.3.3, after confirming that the operation procedures of 2.3.1 and 2.3.2 are finished, disassembling and separating the detachable female joint 12 and the detachable male joint 13 on the blood conveying pipe 11, immediately butting and screwing the detachable male joint 13 on the prepared new blood conveying pipe 11 and the detachable female joint 12 on the original blood conveying pipe 11 which is just disassembled, and restarting the treatment;
2.3.4 if the original state is 2.3.1 and blood is being collected, after finishing the 2.3.3 procedures and confirming that the scalp acupuncture is not coagulated blood, starting a negative pressure key of the trioxane therapeutic apparatus, opening a flow stopping clamp 17 and a flow regulator 15 on the blood conveying pipe 11, and continuing to collect blood;
2.3.5 when the original state is 2.3.2 and the blood is being returned, after finishing the 2.3.3 procedure, after confirming that the scalp needle is not coagulated blood, opening the negative pressure key of the trioxane therapeutic apparatus first, then opening the flow stopping clamp 17 and the flow regulator 15 on the blood conveying pipe 11 in sequence, sucking the newly collected blood into the fusion bottle, immediately closing the negative pressure key of the trioxane therapeutic apparatus after mixing with the original blood in the fusion bottle, closing the flow stopping clamp 17 on the negative pressure gas conveying pipe 9, opening the flow stopping clamp 17 on the positive pressure gas conveying pipe 8, opening the positive pressure key of the trioxane therapeutic apparatus, and returning the residual blood in the fusion bottle;
2.3.6 if the scalp needle is coagulated, immediately drawing out the scalp needle from vein, and sticking the adhesive or bandage on the original puncture site to prevent infection; then a new scalp needle is taken to be connected and screwed with the needle connector 16 on the new blood transfusion tube 11, a new puncture part is selected to be inserted, after the successful blood return of puncture is confirmed, if the original blood sampling state is reached, the operation is carried out according to the 2.3.4 program, and the blood sampling is continued; if the feedback state is originally the feedback state, the operation is carried out according to the program of 2.3.5, and the feedback is continued.
Thirdly, the disposable three oxygen autoblood treatment pipeline has the unique advantages that:
3.1 the disposable three oxygen autoblood disposal pipeline bottle body of the utility model is integrated with the medicine feeding pipeline, the gas transmission pipeline and the blood transfusion pipeline, thereby not only solving the trouble of the existing three oxygen autoblood fusion device vacuum bottle existing assembly, but also solving the trouble of the vacuum bottle of cracking, bottle explosion and foreign matter; the harm of four open pollutions and two chemical substances to the pollution of the treated blood in the treatment of the plastic blood bag is also solved, the amount of the blood which can be treated by three oxidization in one treatment is greatly increased and is N times of the amount of the one treatment of the plastic blood bag, so the curative effect is better and more durable;
3.2 the disposable three oxygen autoblood treatment pipeline of the utility model also effectively solves the difficult problems of long-term disturbance of the blockage and blood coagulation of the three oxygen autoblood therapy blood transfusion pipeline, and the utility model discloses a detachable assembled detachable male joint and a detachable female joint when the blockage or blood coagulation occurs;
3.3 the disposable three oxygen autoblood treatment pipeline of the utility model can be applied to small-dose three oxygen autoblood therapy and large-dose three oxygen autoblood therapy, and can be totally closed without opening and pollution, thus greatly improving the medical safety;
3.4 the utility model discloses disposable three oxygen autoblood handles uses the pipeline capacity big, once adopts and transfects can three oxidation treatment 200ml blood, once treatment can adopt and transfects three oxidation treatment N200 ml blood according to the state of an illness needs, compare with treating with the blood bag once and can only handle 100ml, can save N blood bags, show the reduction medical cost, but greatly increased the clinical treatment income of N times;
3.5 the disposable three oxygen autoblood treatment pipeline of the utility model has the treatment capacity once equal to the treatment capacity of the blood bag for N times, the pain of a patient caused by a vein puncture N needle can be reduced, and the pain of going to and fro a hospital for N times can be reduced; the treatment nurse can also reduce the workload of N times of venipuncture treatment.
The above description is only a preferred embodiment of the present invention, and should not be taken as limiting the invention, and any modifications, equivalent replacements, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (8)
1. A disposable three oxygen autoblood treatment pipeline is characterized by comprising an integrally formed fusion bottle, wherein the fusion bottle comprises a bottle body (1) and three communicating pipes (2), the communicating pipes (2) are communicated with the inside of the bottle body (1), the first communicating pipe (2) is connected with a medicine adding pipe (3) into a whole, the second communicating pipe (2) is connected with a gas conveying pipe (6) into a whole, and the third communicating pipe (2) is connected with a gas conveying pipe (11) into a whole; the gas transmission pipe (6) is provided with a gas transmission tee joint (7), and the gas transmission tee joint (7) is respectively connected with a positive pressure gas transmission pipe (8) and a negative pressure gas transmission pipe (9); the tail ends of the positive pressure air conveying pipe (8) and the negative pressure air conveying pipe (9) are respectively provided with a connector (10); the transfusion tube (11) is fixedly connected with the lower part of the bottle body (1), the transfusion tube is respectively provided with a detachable female connector (12), a detachable male connector (13), a drip cup (14), a flow regulator (15) and a needle head connector (16), the positive pressure gas pipe (8), the negative pressure gas pipe (9) and the transfusion tube (11) are respectively provided with a flow stopping clamp (17), and the connector (10) and the needle head connector (16) are respectively detachably connected with a protective cap (18).
2. The disposable trioxane autoblood treatment line according to claim 1, wherein the dosing tube (3) is blocked by a rubber elastic member.
3. The disposable trioxane autoblood treatment line according to claim 2, wherein the drug feeding tube (3) and the communicating tube (2) are fixedly connected to the upper left portion of the bottle body (1).
4. The disposable trioxane autoblood treatment line according to claim 2, wherein a drug feeding tube protective cap (4) is detachably connected to the drug feeding tube (3).
5. The disposable trioxane autoblood treatment line according to claim 1 or 2, wherein the fusion bottle is formed by one-time injection molding of an acrylonitrile-styrene copolymer material.
6. The disposable trioxane autoblood treatment line according to claim 1, wherein the fusion bottle has a capacity of 300 ml.
7. The disposable trioxane autoblood treatment line according to claim 1, wherein the fusion bottle further comprises a hook (5), and the hook (5) is fixedly connected to the upper portion of the fusion bottle.
8. The disposable trioxane autoblood treatment line according to claim 1, wherein said fusion bottle is transparent to light, and said fusion bottle is provided with scale marks.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022044147.4U CN213759849U (en) | 2020-09-17 | 2020-09-17 | Disposable three oxygen autoblood handles and uses pipeline |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022044147.4U CN213759849U (en) | 2020-09-17 | 2020-09-17 | Disposable three oxygen autoblood handles and uses pipeline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN213759849U true CN213759849U (en) | 2021-07-23 |
Family
ID=76905003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202022044147.4U Active CN213759849U (en) | 2020-09-17 | 2020-09-17 | Disposable three oxygen autoblood handles and uses pipeline |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN213759849U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112156257A (en) * | 2020-09-17 | 2021-01-01 | 张宏石 | Disposable three oxygen autoblood handles and uses pipeline |
-
2020
- 2020-09-17 CN CN202022044147.4U patent/CN213759849U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112156257A (en) * | 2020-09-17 | 2021-01-01 | 张宏石 | Disposable three oxygen autoblood handles and uses pipeline |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2604240Y2 (en) | Medical equipment | |
| CN213759849U (en) | Disposable three oxygen autoblood handles and uses pipeline | |
| CN206613004U (en) | A kind of anti-acupuncture implantable drug delivery system special needle | |
| CN213759848U (en) | Disposable blood handles uses pipeline | |
| CN216963035U (en) | Puncture type medicine suction device for electric injector | |
| CN205268759U (en) | Medical needle receptacle | |
| CN112156257A (en) | Disposable three oxygen autoblood handles and uses pipeline | |
| CN203577022U (en) | Ozone therapeutic instrument | |
| CN203564611U (en) | Disposable secondary filter infusion device | |
| CN112089912A (en) | Disposable blood handles uses pipeline | |
| CN212631340U (en) | Transfusion system | |
| CN207041704U (en) | A kind of disposable transfusion device | |
| CN201143331Y (en) | Disposable filtering injection syringe | |
| CN202620229U (en) | Pharmacy intravenous admixture pipeline and pharmacy intravenous admixture pump | |
| CN211214749U (en) | Medical treatment filter that dispenses | |
| CN201006088Y (en) | Multi-purpose disposable infusion set | |
| CN211432941U (en) | Safety indwelling blood taking needle | |
| CN203970912U (en) | Disposable totally-enclosed suction, injection connector makes up a prescription | |
| CN201759922U (en) | Disposable safe precision filtering infusion set | |
| CN209019593U (en) | A double-ended blood transfusion device | |
| CN205252202U (en) | Dedicated transfusion device for chemotherapy | |
| JP2002248166A (en) | Chemical injector | |
| CN222426161U (en) | Multifunctional internal fistula puncture needle | |
| CN201153985Y (en) | Disposable blood collection and infusion multi-purpose needle | |
| CN202289021U (en) | Novel transfusion device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |